<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02553629</url>
  </required_header>
  <id_info>
    <org_study_id>NL52829.058.15</org_study_id>
    <nct_id>NCT02553629</nct_id>
  </id_info>
  <brief_title>Effect of Deep Neuromuscular Block on Surgical Conditions in Morbidly Obese Patients</brief_title>
  <acronym>BLISS3</acronym>
  <official_title>Effect of Depth of Neuromuscular Block on Intraoperative Surgical Conditions as Determined by the Leiden Surgical Rating Scale in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical Center Haaglanden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Leiden University Medical Center</source>
  <brief_summary>
    <textblock>
      This is a randomized control trial (RCT) that studies the surgical conditions during moderate
      and deep neuromuscular blockade in 100 morbidly obese patients receiving elective
      laparoscopic surgery for bariatric surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical Rating</measure>
    <time_frame>intraoperative</time_frame>
    <description>During a procedure, the surgical condition will be scored by one surgeon using a 5-point surgical rating. This will be done at 10 min intervals from the start of surgery until the end of surgery scale. The rating scale is a 5-point ordinal scale ranging from 1 = poor condition to 5 = optimal surgical conditions. The mean difference in ratings between procedures under deep neuromuscular block and those during moderate neuromuscular block will be evaluated.
The rating scale will be averaged for each subject and the mean values will be reported.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Extubation</measure>
    <time_frame>intraoperative</time_frame>
    <description>The investigators will assess the time from the injection of the reversal agent until the time to removal of the endotracheal tune (extubation).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>postoperative, for up to 2 hours</time_frame>
    <description>pain will be scored using numeric rating scale (0-10, with 0 = no pain and 10 = most pain imaginable), at 10 minute intervals at the post anesthesia care unit, but only the mean value will be used in the analysis and reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiration</measure>
    <time_frame>2 hours postoperative</time_frame>
    <description>Respiration will be measured by counting the respiratory rate at 10 min interval for 2 hours in the post anesthesia care unit. The breaths per min (unit 1/min) will be logged.
The data were averaged per subject and the mean of the mean data are reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Arterial Blood Pressure</measure>
    <time_frame>2 hours postoperative</time_frame>
    <description>Mean arterial pressure (MAP in mmHg) will be monitored at 10 minute intervals for 2 hours in the post anesthesia care unit.
The data will be averaged per subject and the mean of the mean values are reported.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">109</enrollment>
  <condition>Surgical Conditions</condition>
  <arm_group>
    <arm_group_label>moderate neuromuscular block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>rocuronium 0.1-0.6 mg/kg aimed at a train of four of 1 - 2 twitches</description>
  </arm_group>
  <arm_group>
    <arm_group_label>deep neuromuscular block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rocuronium 0.1-0.6 mg/kg aimed at a post tetanic count of 1 - 2 twitches</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium</intervention_name>
    <arm_group_label>moderate neuromuscular block</arm_group_label>
    <arm_group_label>deep neuromuscular block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-III

          -  BMI &gt; 34 kg/m2

          -  Elective bariatric surgery.

        Exclusion Criteria:

          -  Known or suspected neuromuscular disorders impairing neuromuscular function

          -  Allergies to muscle relaxants, anesthetics or narcotics

          -  A(family) history of malignant hyperthermia

          -  Women who are or may be pregnant or are currently breast feeding

          -  Renal insufficiency, as defined by serum creatinine x 2 of normal, or urine output &lt;
             0.5 ml/kg/h for at least 6 h.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Albert Dahan, MD, PhD, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>LUMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medisch Centrum Haaglanden / Nederlandse Obesitas Kliniek</name>
      <address>
        <city>The Hague</city>
        <state>Zuid Holland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Center</name>
      <address>
        <city>Leiden</city>
        <state>Zuid-Holland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2015</study_first_submitted>
  <study_first_submitted_qc>September 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2015</study_first_posted>
  <results_first_submitted>July 14, 2016</results_first_submitted>
  <results_first_submitted_qc>December 11, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 3, 2017</results_first_posted>
  <last_update_submitted>December 11, 2016</last_update_submitted>
  <last_update_submitted_qc>December 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Leiden University Medical Center</investigator_affiliation>
    <investigator_full_name>Albert Dahan</investigator_full_name>
    <investigator_title>MD, PhD, professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Moderate Neuromuscular Block</title>
          <description>rocuronium 0.1-0.6 mg/kg aimed at a train of four of 1 - 2 twitches
Rocuronium</description>
        </group>
        <group group_id="P2">
          <title>Deep Neuromuscular Block</title>
          <description>rocuronium 0.1-0.6 mg/kg aimed at a post tetanic count of 1 - 2 twitches
Rocuronium</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="53"/>
                <participants group_id="P2" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Logistic reasons</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Moderate Neuromuscular Block</title>
          <description>rocuronium 0.1-0.6 mg/kg aimed at a train of four of 1 - 2 twitches
Rocuronium</description>
        </group>
        <group group_id="B2">
          <title>Deep Neuromuscular Block</title>
          <description>rocuronium 0.1-0.6 mg/kg aimed at a post tetanic count of 1 - 2 twitches
Rocuronium</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.9" spread="10.6"/>
                    <measurement group_id="B2" value="47.2" spread="11.1"/>
                    <measurement group_id="B3" value="47.1" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Surgical Rating</title>
        <description>During a procedure, the surgical condition will be scored by one surgeon using a 5-point surgical rating. This will be done at 10 min intervals from the start of surgery until the end of surgery scale. The rating scale is a 5-point ordinal scale ranging from 1 = poor condition to 5 = optimal surgical conditions. The mean difference in ratings between procedures under deep neuromuscular block and those during moderate neuromuscular block will be evaluated.
The rating scale will be averaged for each subject and the mean values will be reported.</description>
        <time_frame>intraoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Moderate Neuromuscular Block</title>
            <description>rocuronium 0.1-0.6 mg/kg aimed at a train of four of 1 - 2 twitches
Rocuronium</description>
          </group>
          <group group_id="O2">
            <title>Deep Neuromuscular Block</title>
            <description>rocuronium 0.1-0.6 mg/kg aimed at a post tetanic count of 1 - 2 twitches
Rocuronium</description>
          </group>
        </group_list>
        <measure>
          <title>Surgical Rating</title>
          <description>During a procedure, the surgical condition will be scored by one surgeon using a 5-point surgical rating. This will be done at 10 min intervals from the start of surgery until the end of surgery scale. The rating scale is a 5-point ordinal scale ranging from 1 = poor condition to 5 = optimal surgical conditions. The mean difference in ratings between procedures under deep neuromuscular block and those during moderate neuromuscular block will be evaluated.
The rating scale will be averaged for each subject and the mean values will be reported.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="0.7"/>
                    <measurement group_id="O2" value="4.8" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Extubation</title>
        <description>The investigators will assess the time from the injection of the reversal agent until the time to removal of the endotracheal tune (extubation).</description>
        <time_frame>intraoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Moderate Neuromuscular Block</title>
            <description>rocuronium 0.1-0.6 mg/kg aimed at a train of four of 1 - 2 twitches
Rocuronium</description>
          </group>
          <group group_id="O2">
            <title>Deep Neuromuscular Block</title>
            <description>rocuronium 0.1-0.6 mg/kg aimed at a post tetanic count of 1 - 2 twitches
Rocuronium</description>
          </group>
        </group_list>
        <measure>
          <title>Extubation</title>
          <description>The investigators will assess the time from the injection of the reversal agent until the time to removal of the endotracheal tune (extubation).</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1" upper_limit="6"/>
                    <measurement group_id="O2" value="3" lower_limit="1" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain</title>
        <description>pain will be scored using numeric rating scale (0-10, with 0 = no pain and 10 = most pain imaginable), at 10 minute intervals at the post anesthesia care unit, but only the mean value will be used in the analysis and reported.</description>
        <time_frame>postoperative, for up to 2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Moderate Neuromuscular Block</title>
            <description>rocuronium 0.1-0.6 mg/kg aimed at a train of four of 1 - 2 twitches
Rocuronium</description>
          </group>
          <group group_id="O2">
            <title>Deep Neuromuscular Block</title>
            <description>rocuronium 0.1-0.6 mg/kg aimed at a post tetanic count of 1 - 2 twitches
Rocuronium</description>
          </group>
        </group_list>
        <measure>
          <title>Pain</title>
          <description>pain will be scored using numeric rating scale (0-10, with 0 = no pain and 10 = most pain imaginable), at 10 minute intervals at the post anesthesia care unit, but only the mean value will be used in the analysis and reported.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" spread="1.4"/>
                    <measurement group_id="O2" value="3.9" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.04</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Respiration</title>
        <description>Respiration will be measured by counting the respiratory rate at 10 min interval for 2 hours in the post anesthesia care unit. The breaths per min (unit 1/min) will be logged.
The data were averaged per subject and the mean of the mean data are reported.</description>
        <time_frame>2 hours postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Moderate Neuromuscular Block</title>
            <description>rocuronium 0.1-0.6 mg/kg aimed at a train of four of 1 - 2 twitches
Rocuronium</description>
          </group>
          <group group_id="O2">
            <title>Deep Neuromuscular Block</title>
            <description>rocuronium 0.1-0.6 mg/kg aimed at a post tetanic count of 1 - 2 twitches
Rocuronium</description>
          </group>
        </group_list>
        <measure>
          <title>Respiration</title>
          <description>Respiration will be measured by counting the respiratory rate at 10 min interval for 2 hours in the post anesthesia care unit. The breaths per min (unit 1/min) will be logged.
The data were averaged per subject and the mean of the mean data are reported.</description>
          <units>breaths per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.7" spread="0.7"/>
                    <measurement group_id="O2" value="12.6" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Arterial Blood Pressure</title>
        <description>Mean arterial pressure (MAP in mmHg) will be monitored at 10 minute intervals for 2 hours in the post anesthesia care unit.
The data will be averaged per subject and the mean of the mean values are reported.</description>
        <time_frame>2 hours postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Moderate Neuromuscular Block</title>
            <description>rocuronium 0.1-0.6 mg/kg aimed at a train of four of 1 - 2 twitches
Rocuronium</description>
          </group>
          <group group_id="O2">
            <title>Deep Neuromuscular Block</title>
            <description>rocuronium 0.1-0.6 mg/kg aimed at a post tetanic count of 1 - 2 twitches
Rocuronium</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Arterial Blood Pressure</title>
          <description>Mean arterial pressure (MAP in mmHg) will be monitored at 10 minute intervals for 2 hours in the post anesthesia care unit.
The data will be averaged per subject and the mean of the mean values are reported.</description>
          <units>millimeters of mercury</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98" spread="13"/>
                    <measurement group_id="O2" value="101" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Moderate Neuromuscular Block</title>
          <description>rocuronium 0.1-0.6 mg/kg aimed at a train of four of 1 - 2 twitches
Rocuronium</description>
        </group>
        <group group_id="E2">
          <title>Deep Neuromuscular Block</title>
          <description>rocuronium 0.1-0.6 mg/kg aimed at a post tetanic count of 1 - 2 twitches
Rocuronium</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Dr. A. Dahan</name_or_title>
      <organization>Leiden University Medical Center</organization>
      <phone>+31 71 526 2301</phone>
      <email>a.dahan@lumc.nl</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

